Top Mesothelioma Centers in Michigan

The leading cancer centers for mesothelioma treatment in Michigan include 2 National Cancer Institute-Designated comprehensive cancer centers: the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center. Both are recognized nationwide for innovative cancer research and expertise in treating complex cases such as peritoneal and pleural mesothelioma.

Organizations that have NCI backing meet the highest standards for cancer care, evidence-based treatment, education and support services. This type of mesothelioma treatment revolves around personalized therapies, multidisciplinary medical teams and minimally invasive surgery techniques.

Locations of Michigan’s Top Cancer Centers

2 of Michigan’s top locations for mesothelioma treatment are the state’s NCI-Designated cancer centers, Rogel Cancer Center in Ann Arbor and the Karmanos Cancer Institute in Detroit. Families who live in Western Michigan can access radiation oncology at the University of Michigan Health West Cancer Center in Kent County. Other cancer centers in the Grand Rapids region also provide medical oncology and thoracic cancer treatments.

All Centers (5)

Top Doctors in Michigan

The best mesothelioma doctors are specialists who have decades of experience treating pleural or peritoneal mesothelioma. Depending on the individual’s needs, treatment can require expertise in radiation oncology, thoracic surgery, immunotherapy and internal medicine. Cutting-edge therapies such as robotic surgery and heated chemotherapy allow doctors to target cancer cells with less invasive treatments.

Skilled mesothelioma cancer specialists at the U-M Rogel Cancer Center develop personalized treatment plans tailored to each person’s diagnosis. Finding a physician who understands the complexities of your mesothelioma type is critical for optimal care.

Dr. Raed Alnajjar

Raed Alnajjar

Pleural Specialist | Thoracic Surgery

Expertise:
Cardiothoracic Surgery Structural Heart Disease
Henry Ford Hospital • Detroit, Michigan
View Profile
Expertise:
Cardiothoracic Surgery Structural Heart Disease
Henry Ford Hospital
Detroit, Michigan
View Profile

Dr. Raed Alnajjar is a respected thoracic surgeon at the Henry Ford Cancer Institute in Detroit, Michigan, and the medical director of cardiothoracic surgery at Henry Ford Macomb Medical Pavilion.

Read Bio
Dr. Gregory P. Kalemkerian

Gregory P. Kalemkerian

Pleural Specialist | Medical Oncology

Expertise:
Thoracic Malignancies Immunotherapy
Rogel Cancer Center at University of Michigan • Ann Arbor, Michigan
View Profile
Expertise:
Thoracic Malignancies Immunotherapy
Rogel Cancer Center at University of Michigan
Ann Arbor, Michigan
View Profile

Dr. Gregory P. Kalemkerian has dedicated his time to researching effective treatments for lung cancer and mesothelioma. Throughout his career as a medical oncologist, he has acted as an unparalleled resource for his patients.

Read Bio
Dr. Richard Berri

Richard Berri

Peritoneal Specialist | Thoracic Surgery

Expertise:
Cytoreductive Surgery HIPEC
Van Elslander Cancer Center •  Grosse Pointe Woods, Michigan
View Profile
Expertise:
Cytoreductive Surgery HIPEC
Van Elslander Cancer Center
 Grosse Pointe Woods, Michigan
View Profile

Dr. Richard Berri is a renowned thoracic surgeon at St. John Hospital and Medical Center in Detroit. Berri is known for his surgical skill and his eagerness to collaborate with other specialists to deliver optimal care to his patients.

Read Bio
Dr. Hirva Mamdani

Hirva Mamdani

Pleural Specialist | Medical Oncology

Expertise:
Immunotherapy Research
Barbara Ann Karmanos Cancer Institute • Detroit, Michigan
View Profile
Expertise:
Immunotherapy Research
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan
View Profile

Dr. Hirva Mamdani is a respected medical oncologist at Barbara Ann Karmanos Cancer Institute in Detroit. She specializes in the treatment of thoracic malignancies, including lung cancer and pleural mesothelioma.

Read Bio
Dr. Mohammad Muhsin Chisti

Mohammad Muhsin Chisti

Pleural Specialist | Medical Oncology

Expertise:
Immunotherapy Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute • Troy, Michigan
View Profile
Expertise:
Immunotherapy Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute
Troy, Michigan
View Profile

Respected medical oncologist Dr. Mohammad Chisti treats a wide range of cancer patients, including those with pleural mesothelioma, at Beaumont Hospital in Troy, Michigan.

Read Bio
Dr. Miguel Alvelo-Rivera

Miguel Alvelo-Rivera

Pleural Specialist | Thoracic Surgery

Expertise:
Minimally Invasive Surgery Thoracoscopic Pneumonectomy
MidMichigan Medical Center-Midland • Midland, Michigan
View Profile
Expertise:
Minimally Invasive Surgery Thoracoscopic Pneumonectomy
MidMichigan Medical Center-Midland
Midland, Michigan
View Profile

Dr. Miguel Alvelo-Rivera is a thoracic surgeon and key member of the comprehensive cancer care team at MidMichigan Health in Midland.

Read Bio
Dr. Shirish Gadgeel

Shirish Gadgeel

Pleural Specialist | Medical Oncology

Expertise:
Thoracic Malignancies Clinical Research
Henry Ford Hospital • Detroit, Michigan
View Profile
Expertise:
Thoracic Malignancies Clinical Research
Henry Ford Hospital
Detroit, Michigan
View Profile

Dr. Shirish Gadgeel is a medical oncologist at the Henry Ford Cancer Institute in Detroit, where he serves as associate director of patient experience and clinical care.

Read Bio
Dr. Craig W. Stevens

Craig W. Stevens

Pleural Specialist | Radiation Oncology

Expertise:
Intensity-Modulated Radiation Therapy Clinical Trials
Beaumont Hospital, Royal Oak • Royal Oak, Michigan
View Profile
Expertise:
Intensity-Modulated Radiation Therapy Clinical Trials
Beaumont Hospital, Royal Oak
Royal Oak, Michigan
View Profile

Dr. Craig Stevens is the department chair for radiation oncology at the Beaumont Cancer Center in Royal Oak, Michigan, where he helped build a mesothelioma treatment program. He is a pioneer in the development of Intensity Modulated Radiation Therapy, and he leads clinical trials testing new drugs and radiation techniques.

Read Bio
Find a Specialist Near You

Begin your search for a doctor in your area.

Searching…

Get started by selecting location, type, specialty or language.

Clinical Trials in Michigan

Leading mesothelioma cancer centers in Michigan prioritize research and clinical trials to advance mesothelioma treatment, including Henry Ford Cancer, the Karmanos Cancer Institute and the U-M Rogel Cancer Center. Clinical trials are valuable because they can offer access to therapies and targeted immunotherapy drugs that may not be widely available. If you’re interested in enrolling in a mesothelioma clinical trial, our Patient Advocates can answer your questions and guide you as you explore your options. 

NCT06756035

CT-95 in Advanced Cancers Associated With Mesothelin Expression

This is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor activity of single-agent CT-95 in subjects with advanced (recurrent, unresectable, or metastatic) cancers associated with MSLN expression.

Locations

  • Colorado (1)

    • Context Investigational Site — Denver

  • Illinois (1)

    • Context Investigational Site — Chicago

  • Michigan (1)

    • Context Investigational Site — Grand Rapids

  • New Jersey (1)

    • Context Investigational Site — Hackensack

  • Pennsylvania (2)

    • University of Pennsylvania — Philadelphia
    • Context Investigational Site — Philadelphia

  • Tennessee (1)

    • Context Investigational Site — Nashville

  • Texas (2)

    • Context Investigational Site — San Antonio
    • Context Investigational Site — San Antonio

NCT05732831

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific MTAP-deleted tumor types. The study drug, TNG462, is a selective PRMT5 inhibitor administered orally. The study is planned to treat up to 225 participants.

Locations

  • California (1)

    • Stanford University — Palo Alto

  • Colorado (1)

    • Grand Valley Oncology — Grand Junction

  • Florida (1)

    • Sylvester Comprehensive Cancer Center — Miami

  • Illinois (3)

    • University Chicago Medicine — Chicago
    • Carle Cancer Center — Urbana
    • Midwestern Regional Medical Center, City of Hope Chicago — Zion

  • Massachusetts (2)

    • Massachusetts General Hospital — Boston
    • Dana Farber Cancer Institute — Boston

  • Michigan (1)

    • Henry Ford Cancer Center — Detroit

  • New York (1)

    • New York University Langone Health — New York

  • Tennessee (1)

    • Sarah Cannon Tennessee Oncology — Nashville

  • Texas (1)

    • The University of Texas MD Anderson Cancer Center — Houston

  • Utah (1)

    • Huntsman Cancer Institute, University of Utah — Salt Lake City

  • Virginia (1)

    • Next Oncology Virginia — Fairfax

NCT05086692

A Beta-only IL-2 ImmunoTherapY Study

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.

Locations

  • California (2)

    • Sharp Memorial Hospital — San Diego
    • Providence Saint John's Health Center — Santa Monica

  • Florida (1)

    • Boca Raton Regional Hospital — Boca Raton

  • Georgia (1)

    • Emory – Winship Cancer Institute — Atlanta

  • Michigan (1)

    • Karmanos Cancer Institute — Detroit

NCT05245500

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid tumor malignancy with homozygous deletion of the MTAP gene.

Locations

  • Arizona (1)

    • Mayo Clinic — Phoenix

  • Colorado (1)

    • Rocky Mountain Cancer Centers, LLP – Oncology — Lone Tree

  • Florida (2)

    • Mayo Clinic — Jacksonville
    • Sarah Cannon Research Institute at Florida Cancer Specialists — Orlando

  • Massachusetts (1)

    • Dana-Farber Cancer Institute — Brookline

  • Michigan (2)

    • The Cancer & Hematology Centers — Grand Rapids
    • Cancer and Hematology Centers of Western Michigan — Norton Shores

  • Minnesota (1)

    • Mayo Clinic — Rochester

  • New Jersey (1)

    • Rutgers Cancer Institute of New Jersey — New Brunswick

  • New York (4)

    • Perlmutter Cancer Center at NYU Langone Hospital Long Island — Mineola
    • David H Koch, Memorial Sloan Kettering Cancer Center — New York
    • New york cancer and blood specialists – Oncology — Port Jefferson Station
    • New york cancer and blood specialists – Oncology — Port Jefferson Station

  • North Carolina (2)

    • University of North Carolina – Gastroenterology and Hepatology — Chapel Hill
    • University of North Carolina — Chapel Hill

  • Tennessee (1)

    • Vanderbilt – Ingram Cancer Center — Nashville

  • Texas (5)

    • Ut Southwestern — Dallas
    • Texas Oncology – DFW — Fort Worth
    • MDACC — Houston
    • South Texas Accelerated Research Therapeutics — San Antonio
    • Texas Oncology, P.A. – Oncology — Tyler

  • Virginia (1)

    • Virginia Cancer Specialists, PC — Fairfax

NCT05579366

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable).

Locations

  • Arizona (2)

    • USOR HonorHealth — Phoenix
    • USOR Arizona Oncology Associates — Tucson

  • California (4)

    • University of California Los Angeles Medical Center — Los Angeles
    • University of California, San Diego; Moores Cancer Center — San Diego
    • USOR Sansum Clinic — Santa Barbara
    • Providence Medical Foundation — Santa Rosa

  • Florida (3)

    • USOR Florida Cancer Specialists South — Fort Myers
    • USOR Florida Cancer Specialists North — St. Petersburg
    • USOR Florida Cancer Specialists East — West Palm Beach

  • Georgia (1)

    • Augusta University Georgia Cancer Center — Augusta

  • Kansas (1)

    • University of Kansas Medical Center (KUMC) — Westwood

  • Maryland (1)

    • USOR Maryland Oncology Hematology — Rockville

  • Massachusetts (2)

    • Massachusetts General Hospital — Boston
    • Dana Farber Cancer Institute — Boston

  • Michigan (2)

    • Karmanos Cancer Institute — Detroit
    • START Midwest — Grand Rapids

  • Minnesota (1)

    • USOR Minnesota Oncology Hematology — Maplewood

  • New Jersey (1)

    • MD Anderson Cancer Center at Cooper- Two Cooper Plaza — Camden

  • Ohio (1)

    • Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute — Columbus

  • Oklahoma (1)

    • University of Oklahoma – Health Sciences Center — Oklahoma City

  • Oregon (2)

    • USOR Oncology Associates of Oregon, P.C. — Eugene
    • Compass Oncology – Rose Quarter — Portland

  • Pennsylvania (2)

    • USOR Alliance Cancer Specialist — Doylestown
    • Allegheny Health Network — Pittsburgh

  • Rhode Island (1)

    • Women and Infants Hospital of Rhode Island — Providence

  • Tennessee (2)

    • Sarah Cannon Research Institute at Tennessee Oncology — Nashville
    • Tennessee Oncology — Nashville

  • Texas (6)

    • USOR Texas Oncology — Abilene
    • Texas Oncology – Central / South Texas — Austin
    • Mary Crowley Cancer Research — Dallas
    • USOR Texas Oncology — Fort Worth
    • Texas Oncology – Northeast TX — Tyler
    • USOR Texas Oncology Gulf Coast — Woodland

  • Utah (1)

    • START Mountain Region — West Valley City

  • Virginia (2)

    • USOR Virginia Cancer Specialists — Fairfax
    • USOR Virginia Oncology Associates — Norfolk

  • Washington (1)

    • Swedish Cancer Institute — Seattle

Financial Support for Treatment in Michigan

Many nonprofits in Michigan provide financial assistance for those with cancer who are facing economic hardships due to treatment costs, from statewide organizations such as Angels of Hope to county-specific programs like Community Cancer Services of Isabella County. Some aid groups help with medical care expenses, and others support people with mesothelioma by covering insurance premiums, gas, rent and everyday essentials.

Financial Aid for People with Mesothelioma in Michigan

  • American Cancer Society: The American Cancer Society operates cancer resource centers that provide free wigs, hats, treatment information and other assistance. The organization can help Michigan families access emotional support, financial aid and lodging when traveling for treatment.
  • .Angels of Hope: This well-known Michigan nonprofit offers short-term grants to families facing a cancer diagnosis, helping with groceries, utility bills and more. To qualify, you must reside in Michigan, be in active treatment, face financial hardship due to their diagnosis and have a dependent minor at home.
  • Community Cancer Services of Isabella County: This nonprofit provides targeted financial aid to people with cancer in Mount Pleasant and other areas of Isabella County, mainly covering travel and lodging costs related to treatment.
  • Meagan’s Way Foundation: Meagan’s Way Foundation is a Macomb County nonprofit that provides emergency financial aid to people dealing with financial problems due to the cost of cancer care. Funds can cover many needs, including rent, mortgage payments and home modifications related to recovery.
  • Mission of Hope Cancer Fund: Based in Jackson, Mission of Hope Cancer Fund provides financial aid to people with mesothelioma throughout Michigan. The program can help with treatment and recovery costs, including co-pays, travel expenses, lodging and medical supplies.
  • New Day Foundation: This Rochester Hills charity provides emergency living assistance to Michigan families facing cancer. New Day Foundation pays for food, gas and other critical expenses. The nonprofit also supports those living with mesothelioma by connecting them with a network of licensed mental health professionals.

Our Patient Advocates have connected people in Michigan with top doctors and cancer centers for more than 15 years. Through resources such as support groups, webinars with experts and VA-accredited claims agents, we help families schedule medical appointments, navigate insurance, seek financial assistance and get second opinions.

Cancer Resources in Michigan

Families facing mesothelioma in Michigan have access to many free county, state and national resources for cancer care. Organizations such as Cancer Services Midland and Rogel Cancer Center in Ann Arbor provide important physical, emotional, spiritual and practical support, from exercise therapy and recovery programs to caregiver support networks and nutritional assistance.

Free Mesothelioma Support Services in Michigan

  • Cancer Support Community: With multiple locations throughout Michigan, Cancer Support Community puts support programs within reach during diagnosis, treatment and recovery. CSC helps more than 1,000 people each year with free workshops, social activities, counseling, exercise and nutrition services.
  • Mesothelioma Survivor, Caregiver & Family Support: This Facebook group connects people with mesothelioma, survivors and their families in Michigan and across the country. It provides a place to share experiences and offer peer support.
  • Cancer Services: All people with mesothelioma in Midland County can take advantage of free support through Cancer Services Midland, regardless of income. Programs include wellness activities, notary services, personalized nutrition counseling, support groups and transportation assistance. The partner nonprofit Maria Mencia Cancer Caregiver Support Network also offers 1-on-1 support, education and mentorship for caregivers.
  • Revive & Thrive: The Revive & Thrive Project delivers fresh, healthy meals to individuals experiencing medical crises in the Greater Grand Rapids area. The program provides medically supportive food to local people facing mesothelioma, spouses, caregivers and children. Depending on the family’s needs, this meal service lasts 12 to 24 weeks.
  • Rogel Cancer Center: The University of Michigan’s Rogel Cancer Center provides many support services for people with mesothelioma, including art therapy, family programs, support groups and spiritual care. The center also offers compassionate end-of-life programs for people needing those services and grief counseling for family members.
  • One More Moment: The One More Moment charity helps adults with advanced or Stage IV cancers spend meaningful time with loved ones. The Michigan nonprofit fulfills wishes to create family moments, such as sharing a special meal or traveling to a scenic location in the state. The person in treatment, family members, friends or oncology staff can submit the wish application. 

People facing mesothelioma and their caregivers can also dial 211 to learn more about local cancer supports. Seven organizations manage 211 services in Michigan, providing coverage in all counties. These organizations can connect callers with nutritional services like Meals on Wheels, free transportation, home care programs and support groups.

What Survivors Say About Their Mesothelioma Treatment in Michigan

Our team has helped many people with mesothelioma who live in Michigan or visit the state’s well-known cancer centers. These cancer survivors benefited from treatment and seeking help from top doctors and NCI cancer centers like the University of Michigan.

Survivor Experience

“Everyone has been just wonderful with all the support.”

– Chuck G. , Pleural Mesothelioma Survivor
Verified Asbestos.com Survivor

Survivor Experience

“Like with any cancer patient, there are days when you aren’t on top of the world, but the point is not to stay there, to keep moving forward,” she said. “You can’t sit around and wait for something to happen. You can’t dwell on that.”

– Angela W. , Pleural Mesothelioma Survivor
Verified Asbestos.com Survivor